Managing Immune-Related Adverse Events in the ED With the Advent of Combination Therapies
October 27, 2020
October 27, 2021
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Paradigm Medical Communications, LLC.
This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.
This enduring satellite symposium is not part of the official ACEP20 UNCONVENTIONAL educational program as planned by ACEP’s Educational Meetings Committee
- Physicians, Physician's Assistants, Nurse Practitioners — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Emergency Physicians — Approved by the American College of Emergency Physicians for 1.0 hour(s) of ACEP Category I credit
All other healthcare professionals completing this course will be issued a statement of participation.
This activity is designed to meet the educational needs of emergency medicine (EM) clinicians. It may also benefit other members of the multidisciplinary team caring for patients receiving immuno-oncology agents.
As use of immune checkpoint inhibitors (ICI) for various cancers increases, the number of patients presenting to the emergency department (ED) with associated immune-related adverse events (irAEs) will increase as well. This 1.0-hour, CME-certified program, presented by Drs. Christopher J. Coyne and Jayne Viets-Upchurch, will review the fundamentals of ICIs as used for cancer treatment, including standard-of-care regimens and the mechanisms of action for these agents. It will also highlight guideline-recommended approaches to recognizing and treating irAEs associated with ICI monotherapies or combination regimens in the ED setting.
Upon proper completion of this activity, participants should be better able to:
- Review the fundamentals of immune checkpoint inhibition, including standard-of-care regimens and their MOAs
- Apply guideline-recommended approaches to recognizing and treating irAEs associated with immune checkpoint inhibition monotherapies or combination regimens in the ED setting
Christopher J. Coyne, MD, MPH
Assistant Clinical Professor
Radiation Medicine and Applied Science
UC San Diego Health
San Diego, CA
Jayne Viets-Upchurch, MD
Department of Emergency Medicine
Division of Internal Medicine
The University of Texas MD Anderson Cancer Center
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ACEP Category 1 Credit Statement
Approved by the American College of Emergency Physicians for 1.0 hour(s) of ACEP Category I credit.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosures of Conflicts of Interest
In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below. Any potential conflicts of interest have been resolved.
Christopher J. Coyne, MD, MPH
- Has no financial relationships to disclose
Jayne Viets-Upchurch, MD
- Has no financial relationships to disclose
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
Independent peer reviewer:
Marwan Fakih, MD has the following relationships to disclose:
- Consulting Fees: Amgen Inc; Array Biopharma; Bayer Corporation; Pfizer Inc
- Speakers Bureau: Amgen Inc; Guardant 360
Meghan Thomas has no financial relationships to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
Instructions for Participation and Credit
To receive a CME certificate of participation, you should:
- Follow the "Start Activity" button to go to the Paradigm Medical Communications website
- Follow instructions to register or log in with your professional information
- View the online activity in its entirety
- Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest
There is no fee required for participation in this activity.
Course Viewing Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+
Technical Support: If you have any technical problems or playback issues email us at email@example.com.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website"). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
If you have any questions or comments, please email us at firstname.lastname@example.org.
©2020 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.